Abstract:ABSTRACT Human herpesvirus 8 (HHV-8), associated with Kaposi sarcoma, primary effusion lymphoma (PEL), and multicentric Castleman disease, encodes four interferon regulatory factor homologs, vIRFs 1–4, that interact with and inhibit various mediators of host-cell defense against virus infection. A cellular protein targeted by all the vIRFs is ubiquitin-specific protease 7 (USP7); while replication-modulatory and latently infected PEL-cell pro-viability phenotypes of USP7 targeting have been identified for vIRFs 1–3, the significance of the interaction of vIRF-4 with USP7 has remained undetermined. Here we show, through genetic ablation of the vIRF-4-USP7 interaction in infected cells, that vIRF-4 association with USP7 is necessary for optimal expression of vIRF-4 and normal HHV-8 replication. Findings from experiments on transfected and infected cells identified ubiquitination of vIRF-4 via K48-linkage and USP7-binding-associated suppression of vIRF-4 ubiquitination and, in infected cells, increased vIRF-4 expression. Analysis of IFN-I induction and associated signaling as a function of vIRF-4 and its interaction with USP7 identified a role of each in innate-immune suppression. Finally, activation via K63-polyubiquitination of the innate-immune signaling mediator TRAF3 was found to be suppressed by vIRF-4 in a USP7-binding-associated manner in infected cells, but not in transfected cells, likely via binding-regulated expression of vIRF-4. Together, our data identify the first examples of vIRF ubiquitination and a vIRF substrate of USP7, enhanced expression of vIRF-4 via its interaction with USP7, and TRAF3-inhibitory activity of vIRF-4. The findings address, for the first time, the biological significance of the interaction of vIRF-4 with USP7 and reveal a mechanism of vIRF-4-mediated innate-immune evasion and pro-replication activity via TRAF3 regulation. IMPORTANCE HHV-8 homologs of cellular interferon regulatory factors (IRFs), involved in host-cell defense against virus infection, interact in an inhibitory fashion with IRFs and other mediators of antiviral innate immunity. These interactions are of demonstrated or hypothesized importance for successful primary, productive (lytic), and latent (persistent) infection by HHV-8. While HHV-8 vIRF-4 is known to interact physically with USP7 deubiquitinase, a key regulator of various cellular proteins, the functional and biological significance of the interaction has not been addressed. The present study identifies the interaction as important for HHV-8 productive replication and, indeed, for vIRF-4 expression and reveals a new function of vIRF-4 via inhibition of the activity of TRAF3, a pivotal mediator of host-cell antiviral activity through activation of cellular IRFs and induction of type-I interferons. These findings identify potential targets for the development of novel anti-HHV-8 agents, such as those able to disrupt vIRF-4–USP7 interaction or vIRF-4-stabilizing USP7 activity.

Ubiquitin Specific Peptidase 4 Stabilizes Interferon Regulatory Factor Protein and Promotes Its Function to Facilitate Interleukin-4 Expression in T Helper Type 2 Cells.

USP4 Interacts and Positively Regulates IRF8 Function Via K48-linked Deubiquitination in Regulatory T Cells.

Cutting Edge: Ubiquitin-Specific Protease 4 Promotes Th17 Cell Function under Inflammation by Deubiquitinating and Stabilizing RORγt

Usp4 Positively Regulates Rig-I-Mediated Antiviral Response Through Deubiquitination and Stabilization of Rig-I

Expression of USP25 Associates with Fibrosis, Inflammation and Metabolism Changes in IgG4-related Disease

USP12 promotes CD4+ T cell responses through deubiquitinating and stabilizing BCL10

USP1-regulated Reciprocal Differentiation of Th17 Cells and Treg Cells by Deubiquitinating and Stabilizing TAZ.

USP4 Inhibits P53 and NF-κB Through Deubiquitinating and Stabilizing HDAC2

USP4 targets TAK1 to downregulate TNF|[alpha]|-induced NF-|[kappa]|B activation

USP22 Promotes IRF3 Nuclear Translocation and Antiviral Responses by Deubiquitinating the Importin Protein KPNA2

Ubiquitin-specific Protease 4 Mitigates Toll-like/Interleukin-1 Receptor Signaling and Regulates Innate Immune Activation*

Biologically significant interaction of human herpesvirus 8 viral interferon regulatory factor 4 with ubiquitin-specific protease 7

Deubiquitinase USP4 Suppresses Antitumor Immunity by Inhibiting IRF3 Activation and Tumor Cell-Intrinsic Interferon Response in Colorectal Cancer

USP3 Inhibits Type I Interferon Signaling by Deubiquitinating RIG-I-like Receptors

Ubiquitin Specific Protease 5 Negatively Regulates the IFNs-mediated Antiviral Activity Via Targeting SMURF1.

P037 USP16-mediated deubiquitination of calcineurin A controls peripheral T cells maintenance and attenuates intestinal inflammation

Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3.

Ubiquitin-specific Protease 15 Negatively Regulates Virus-induced Type I Interferon Signaling via Catalytically-dependent and -independent Mechanisms

Ubiquitin-Specific Protease 4 (Usp4) Targets Traf2 And Traf6 For Deubiquitination And Inhibits Tnf Alpha-Induced Cancer Cell Migration

USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.

USP4 is Pathogenic in Allergic Airway Inflammation by Inhibiting Regulatory T Cell Response.